Open AccessJournal Article
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more
Reads0
Chats0
About:
This article is published in American Journal of Kidney Diseases.The article was published on 2003-10-01 and is currently open access. It has received 2609 citations till now. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Kidney disease.read more
Citations
More filters
Journal ArticleDOI
Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis
Kazuhiro Yamada,Shouichi Fujimoto,Ryosuke Nishiura,Hiroyuki Komatsu,Mariko Tatsumoto,Yuji Sato,Seiichiro Hara,Shuichi Hisanaga,Hideyuki Ochiai,Hiroyuki Nakao,Tanenao Eto +10 more
TL;DR: The increase of serum calcium after HD was related to the rate of progression of aortic calcification, and excess calcium is transferred into patients on HD when using a dialysate of 3.0 mEq/l calcium may be a risk factor for the development of vascular calcification.
Journal ArticleDOI
Sevelamer Controls Parathyroid Hormone–Induced Bone Disease as Efficiently as Calcium Carbonate without Increasing Serum Calcium Levels during Therapy with Active Vitamin D Sterols
Isidro B. Salusky,William G. Goodman,Shobha Sahney,Barbara Gales,Ashley Perilloux,He-Jing Wang,Robert Elashoff,Harald Jüppner +7 more
TL;DR: Treatment with either CaCO3 or sevelamer resulted in equivalent control of the biochemical and skeletal lesions of 2 degrees HPT, thereby increasing the safety of treatment with active vitamin D sterols.
Journal ArticleDOI
COSMOS: the dialysis scenario of CKD–MBD in Europe
José Luis Fernández-Martín,Juan Jesus Carrero,Miha Benedik,Willem Jan W. Bos,Adrian Covic,Aníbal Ferreira,Jürgen Floege,David Goldsmith,José Luis Górriz,Markus Ketteler,Reinhard Kramar,Francesco Locatelli,Gérard M. London,Pierre-Yves Martin,Dimitrios Memmos,Judit Nagy,Manuel Naves-Díaz,Drasko Pavlovic,Minerva Rodríguez-García,Bolesław Rutkowski,Vladimir Teplan,Christian Tielemans,Dierik Verbeelen,Rudolf P. Wüthrich,Pablo Martínez-Camblor,Iván Cabezas-Rodríguez,José Emilio Sánchez-Alvarez,Jorge B. Cannata-Andía +27 more
TL;DR: The COSMOS baseline results show important differences across Europe in the management of CKD-MBD, and the current practice for the prevention, diagnosis and treatment of secondary hyperparathyroidism is described.
Journal ArticleDOI
Lack of Comparability of Intact Parathyroid Hormone Measurements among Commercial Assays for End-Stage Renal Disease Patients: Implication for Treatment Decisions
TL;DR: Noncomparability among iPTH assays remains a distinct problem for the management of ESRD patients and should be taken into consideration when determining the course of medical treatment based on measured iPTH concentrations.
Journal ArticleDOI
Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease
Juan Jesus Carrero,Peter Bárány,Mahmut Ilker Yilmaz,Abdul Rashid Qureshi,Alper Sonmez,Olof Heimbürger,Tanez Ozgurtas,Mujdat Yenicesu,Bengt Lindholm,Peter Stenvinkel +9 more
TL;DR: It is raised the possibility that restoration of testosterone levels in hypogonadal CKD males may translate into lower prevalence of anaemia and better ESA responsiveness, and the inverse association between testosterone levels and ESA doses persisted after multivariate adjustment but was lost after further adjustment for iron medication and hypochromic RBC.
References
More filters
Journal ArticleDOI
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Geoffrey A. Block,Kevin J. Martin,Angel L.M. de Francisco,Stewart A. Turner,Morrell M. Avram,Michael Suranyi,Gavril Hercz,John Cunningham,Ali K. Abu-Alfa,Piergiorgio Messa,Daniel W. Coyne,Francesco Locatelli,Raphael M. Cohen,Pieter Evenepoel,Sharon M. Moe,Albert Fournier,Johann Braun,Laura C. McCary,Valter J. Zani,Kurt Olson,Tilman B. Drüeke,William G. Goodman +21 more
TL;DR: Cinacalcet lowers parathyroid hormone levels and improves calcium-phosphorus homeostasis in patients receiving hemodialysis who have uncontrolled secondary hyperparathyroidism.